United Therapeutics
UTHR
#1032
Rank
โ‚น1.967 T
Marketcap
โ‚น43,498
Share price
0.65%
Change (1 day)
37.16%
Change (1 year)

Revenue for United Therapeutics (UTHR)

Revenue in 2025 (TTM): โ‚น270.50 Billion

According to United Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น281.09 Billion. In 2024 the company made a revenue of โ‚น246.84 Billion an increase over the revenue in the year 2023 that were of โ‚น193.76 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for United Therapeutics from 1999 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น270.50 B9.59%
2024 โ‚น246.84 B27.39%
2023 โ‚น193.76 B20.93%
2022 โ‚น160.22 B27.72%
2021 โ‚น125.45 B15.65%
2020 โ‚น108.47 B5%
2019 โ‚น103.31 B-9.23%
2018 โ‚น113.81 B3.32%
2017 โ‚น110.16 B1.4%
2016 โ‚น108.64 B11.54%
2015 โ‚น97.40 B19.28%
2014 โ‚น81.66 B18.34%
2013 โ‚น69.00 B37.58%
2012 โ‚น50.15 B27.58%
2011 โ‚น39.31 B46.56%
2010 โ‚น26.82 B56.32%
2009 โ‚น17.16 B26.83%
2008 โ‚น13.53 B63.44%
2007 โ‚น8.27 B17.09%
2006 โ‚น7.07 B35.54%
2005 โ‚น5.21 B63.67%
2004 โ‚น3.18 B31.23%
2003 โ‚น2.42 B68.14%
2002 โ‚น1.44 B422.26%
2001 โ‚น0.27 B189.16%
2000 โ‚น95.64 M340.01%
1999 โ‚น21.73 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eli Lilly
LLY
โ‚น5.339 T 1,799.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น2.613 T 829.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น1.507 T 436.25%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
โ‚น5.641 T 1,906.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚น990.44 B 252.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
โ‚น7.83 B-97.21%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น3.805 T 1,253.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cardinal Health
CAH
โ‚น21.053 T 7,389.77%๐Ÿ‡บ๐Ÿ‡ธ USA